Manufacturer: Novo Nordisk
Pharmaceutical name: Insulin detemir [rDNA origin] injection
Pack: 1 pack (5 pens x 3 ml (100 iu/ml))
Levemir FlexPen is a long-acting insulin designed for managing types 1 and 2 diabetes in both adults and children. It maintains a consistent insulin level in the body over a full day, aiding in the regulation of blood sugar levels and helping to avert diabetes-related complications.
Levemir FlexPen can be prescribed on its own or in combination with a fast-acting insulin or other diabetes medications. Your healthcare provider will instruct you on the proper technique for subcutaneous injection. It is important to administer Levemir FlexPen consistently according to the prescribed dosage to maximize its benefits. Stopping its use may lead to significantly elevated blood sugar levels, increasing the risk of severe complications. It is essential to integrate this medication into a comprehensive treatment plan that includes a nutritious diet, consistent physical activity, and weight management as recommended by your physician.
The most frequent side effect of Levemir FlexPen is low blood sugar (hypoglycemia). To mitigate this risk, it is crucial to inject only the prescribed dosage, eat regularly, and monitor blood sugar levels consistently. Excessive consumption of alcohol can also cause a drop in blood sugar levels. Additional side effects may include allergic reactions at the injection site such as redness, swelling, or lumps (lipohypertrophy). Some individuals may experience weight gain while using insulin.
Avoid using Levemir FlexPen if you have hypoglycemia. Inform your doctor if you have a history of kidney, liver, or heart issues prior to beginning treatment. Generally, it is considered safe for women who are pregnant or breastfeeding, provided it has been prescribed by a healthcare professional.